144 related articles for article (PubMed ID: 23577919)
1. Epistaxis in a kidney transplant recipient: an uncommon presentation of post-transplant lymphoproliferative disease.
Yap DY; Chan GC; Mok MM; Chan TM
Nephrology (Carlton); 2013 Jul; 18(7):531. PubMed ID: 23577919
[No Abstract] [Full Text] [Related]
2. Post-transplant lymphoproliferative disorder presenting as epistaxis.
Clarke JD; Stock D; Singh V
J Laryngol Otol; 2004 Nov; 118(11):906-8. PubMed ID: 15638984
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
[TBL] [Abstract][Full Text] [Related]
4. Native kidney posttransplant lymphoproliferative disorder in a renal transplant recipient.
Chandra A; Kaul A; Aggarwal V; Srivastava D
Saudi J Kidney Dis Transpl; 2017; 28(4):942-944. PubMed ID: 28748904
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
6. Pediatric transplant grand rounds.
Benfield MR; Harmon WE
Pediatr Transplant; 1997 Aug; 1(1):65-72. PubMed ID: 10084789
[No Abstract] [Full Text] [Related]
7. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
Leaver S; Amlot P; Thuraisingham R; Norton A; Aitken C; Cavenagh JD
Clin Lab Haematol; 2004 Oct; 26(5):351-3. PubMed ID: 15485466
[TBL] [Abstract][Full Text] [Related]
8. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
[TBL] [Abstract][Full Text] [Related]
10. EBV-associated recurrent Hodgkin's disease after renal transplantation.
Flanagan KH; Brennan DC
Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
[TBL] [Abstract][Full Text] [Related]
11. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
Clin Nucl Med; 2009 Jun; 34(6):386-7. PubMed ID: 19487854
[No Abstract] [Full Text] [Related]
12. Recurrent septicemia in a renal transplant recipient.
Nejad-Gashti H; Sanavi S; Afshar R
Saudi J Kidney Dis Transpl; 2009 May; 20(3):471-3. PubMed ID: 19414955
[TBL] [Abstract][Full Text] [Related]
13. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
O'Conner AR; Franc BL
Nucl Med Commun; 2005 Dec; 26(12):1107-11. PubMed ID: 16264358
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
Boratyńska M; Smolska D
Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
[No Abstract] [Full Text] [Related]
15. Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation.
Borhani AA; Hosseinzadeh K; Almusa O; Furlan A; Nalesnik M
Radiographics; 2009; 29(4):981-1000; discussion 1000-2. PubMed ID: 19605652
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant lymphoproliferative disease in a pediatric patient as seen on PET/CT scan.
Bagga S
Clin Nucl Med; 2007 Jul; 32(7):553-4. PubMed ID: 17581345
[No Abstract] [Full Text] [Related]
17. Haematological disorders following kidney transplantation.
Malyszko J; Basak G; Batko K; Capasso G; Capasso A; Drozd-Sokolowska J; Krzanowska K; Kulicki P; Matuszkiewicz-Rowinska J; Soler MJ; Sprangers B; Malyszko J
Nephrol Dial Transplant; 2022 Feb; 37(3):409-420. PubMed ID: 33150431
[TBL] [Abstract][Full Text] [Related]
18. Rejection versus posttransplantation lymphoproliferative disorder in a renal transplant recipient.
Troxell ML; Dunlap JB; Mittalhenkle A; Ishag M; Fan G; Huang JZ; Gatter K; Byrd DM; Webster D; Houghton DC
Am J Kidney Dis; 2008 Dec; 52(6):1174-9. PubMed ID: 18706749
[No Abstract] [Full Text] [Related]
19. Post-transplantation lymphoproliferative disorder: an unusual presentation in a patient receiving tacrolimus.
Gallagher H; Kwan JT; Andrews PA
Nephrol Dial Transplant; 2000 Jun; 15(6):928-30. PubMed ID: 10831670
[No Abstract] [Full Text] [Related]
20. Clinical challenges and images in GI. Intestinal posttransplant lymphoproliferative disorder.
Brain O; von Herbay A; Keshav S
Gastroenterology; 2009 May; 136(5):1506, 1845. PubMed ID: 19332168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
